Smallpox vaccine for monkeypox fever
The European Commission has approved the development of Imvanex, an immune vaccine given to weaken the smallpox virus to prevent infection with the monkey flu virus.
Imvanex Imvanex is an immunization vaccine developed by the Bavarian Nordic pharmaceutical company in Europe to eradicate the smallpox virus from the world.
Several such vaccines for smallpox have been developed by the world’s leading pharmaceutical companies.
Imvanex Imvanex vaccine has been developed and mass-produced to control the spread of monkey flu by European member states.
(Reuters)
